Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 75 of 2228 entries
View as:

A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT04656275 Org: User:
Start: 03/04/21 End: 01/19/22 Due: 01/19/23

Describing Patient With DME, Their Patient Journey and Disease Progression

Phase: N/A Priority: Normal
NCT ID: NCT05966753 Org: User:
Start: 08/03/23 End: 12/31/23 Due: 12/31/24

Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02202525 Org: User:
Start: 01/31/01 End: - Due: -

Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02187523 Org: User:
Start: 10/31/99 End: - Due: -

A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.

Phase: N/A Priority: Normal
NCT ID: NCT00274560 Org: User:
Start: 05/01/02 End: - Due: -

Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use

Phase: N/A Priority: Normal
NCT ID: NCT01344629 Org: User:
Start: 04/30/11 End: - Due: -

A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02182674 Org: User:
Start: 10/31/00 End: - Due: -

Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT00657150 Org: User:
Start: 03/31/08 End: - Due: -

A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an Injection

Phase: N/A Priority: Normal
NCT ID: NCT05203289 Org: User:
Start: 02/18/22 End: 08/29/22 Due: 08/29/23

Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02248207 Org: User:
Start: 01/31/03 End: - Due: -

A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication

Phase: N/A Priority: Normal
NCT ID: NCT04937829 Org: User:
Start: 07/20/21 End: 11/16/23 Due: 11/16/24

Determining Optimal Free Dose Combination of Tiotropium Bromide and BI 1744 CL in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01040403 Org: User:
Start: 01/31/10 End: - Due: -

Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01525641 Org: User:
Start: 02/29/12 End: 06/30/14 Due: 06/30/15

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02183350 Org: User:
Start: 04/30/05 End: - Due: -

Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02209727 Org: User:
Start: 12/31/00 End: - Due: -

Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02222961 Org: User:
Start: 11/30/99 End: - Due: -

Investigation of Drug-drug Interaction of Nintedanib and Ketoconazole in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01679613 Org: User:
Start: 09/30/12 End: 11/30/12 Due: 11/30/13

Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis

Phase: N/A Priority: Normal
NCT ID: NCT02229747 Org: User:
Start: 08/31/01 End: - Due: -

Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03195088 Org: User:
Start: 07/27/17 End: 11/14/17 Due: 11/14/18

Single Increasing Doses of BIII 890 CL in Healthy Young Male Volunteers and in Healthy Elderly Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02269215 Org: User:
Start: 01/31/00 End: - Due: -

Early Intervention Efficacy in COPD

Phase: N/A Priority: Normal
NCT ID: NCT04249310 Org: User:
Start: 03/27/20 End: 08/12/20 Due: 08/12/21

A Study in Healthy Men That Tests if Taking BI 1265162 by Mouth, Intravenously, or Inhaled Influences the Amount of BI 1265162 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT03907280 Org: User:
Start: 04/23/19 End: 12/06/19 Due: 12/06/20

Assessment of Health-related Quality of Life After Switching COPD Patients From a Dry Powder Inhaler to a Soft Mist Inhaler Remaining on the Same Inhalative Drug

Phase: N/A Priority: Normal
NCT ID: NCT05362487 Org: User:
Start: 08/05/22 End: 01/18/23 Due: 01/18/24

Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC)

Phase: N/A Priority: Normal
NCT ID: NCT01329549 Org: User:
Start: 04/30/11 End: 10/31/12 Due: 10/31/13

A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity

Phase: N/A Priority: Normal
NCT ID: NCT06352424 Org: User:
Start: 04/30/24 End: 02/24/25 Due: 02/24/26